Macmillan alliance will provide digital health apps to cancer patients
Newly diagnosed cancer patients across the UK will get free access to digital mental health therapies, thanks to a new partnership between Macmillan Cancer Support […]
Newly diagnosed cancer patients across the UK will get free access to digital mental health therapies, thanks to a new partnership between Macmillan Cancer Support […]
After a non-committal appraisal of Big Health’s Sleepio app for insomnia last November in draft guidance from NICE, the cost-effectiveness agency has come out in […]
A digital therapeutic (DTx) developed to help people suffering from insomnia has been shown to improve sleep and mental health in people recovering from a […]
Idorsia has become the first drugmaker in the EU to claim approval for a drug for chronic insomnia in the dual orexin receptor antagonist class, […]
A new treatment for adults with insomnia disorder has been recommended for use in Europe, giving hope to people whose lives are blighted by the […]
The “vampire hormone” can act like a dose of sunset, tricking your body into feeling like it’s time to sleep.
The “vampire hormone” can act like a dose of sunset, tricking your body into feeling like it’s time to sleep.
La “hormona vampiro” puede actuar como una dosis de puesta de sol, al engañar a tu cuerpo para que sienta que es hora de dormir.
La “hormona vampiro” puede actuar como una dosis de puesta de sol, al engañar a tu cuerpo para que sienta que es hora de dormir.
La “hormona vampiro” puede actuar como una dosis de puesta de sol, al engañar a tu cuerpo para que sienta que es hora de dormir.
The “vampire hormone” can act like a dose of sunset, tricking your body into feeling like it’s time to sleep.
Swiss biotech Idorsia has claimed FDA approval for its first product – insomnia treatment Quviviq – setting up a market challenge to class rivals from […]
Big Health’s Sleepio app for insomnia has been cautiously backed by NICE in preliminary guidance, although the cost-effectiveness agency says more data on longer-term use […]
UK-based Big Health has passed a digital health milestone after Scotland became the first country to make anxiety and insomnia digital therapeutics available on a […]
A study has shown that people with anxiety or depression who used a digital therapeutic (DTx) for insomnia alongside psychological therapy, had better improvement in […]
The company recently finished a study showing patients in the U.K. who used both Sleepio’s app and therapy saw improvements in anxiety and depression compared […]
Sleep disturbances are a common feature for people with Parkinson’s disease, and a device developed to help people with insomnia is now being trialled to […]
Eisai Co., Ltd. announced that its Hong Kong subsidiary Eisai (Hong Kong) Co., Ltd. has obtained approval for the in-house-discovered and developed orexin receptor antagonist […]
Shots: The P-III SUNRISE 1 (Study 304) study involves assessing of DAYVIGO (lemborexant, 5 or 10 mg) vs an active comparator or PBO in 1,006 […]
Copyright © 2024 | WordPress Theme by MH Themes